SCHEMBL5201458

SCHEMBL5201458

Cc1ccc(Nc2cc(F)cc(C#N)c2)c(C(=O)Nc2ccn(C)n2)n1

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 4/20 0.47
GRM5 P41594 5/20 0.46
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
CSNK1D P48730 1/20 0.39
CSNK1E P49674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5204681 0.87 PDE10A (0.42) PDE10AGRM5CSNK1DCSNK1E
SCHEMBL5200179 0.87 PDE10A (0.50) PDE10AGRM5NPC1RAB9A
SCHEMBL5201415 0.86 PDE10A (0.54) PDE10AGRM5NPC1RAB9A
SCHEMBL5204946 0.84 PDE10A (0.52) PDE10AGRM5NPC1RAB9A
SCHEMBL5202051 0.83 PDE10A (0.56) PDE10AGRM5NPC1RAB9A
SCHEMBL4909014 0.80 CSNK2A1 (0.45) GRM5NPC1RAB9A
SCHEMBL5202081 0.79 PDE10A (0.63) PDE10AGRM5NPC1RAB9A
SCHEMBL27377264 0.77 PRKD1 (0.43) GRM5
SCHEMBL31457010 0.77 PRKD1 (0.43) GRM5
SCHEMBL5204048 0.77 PDE10A (0.47) PDE10AGRM5NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858854-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2007-11-28 EP claimed
WO-2006094639-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-14 WO claimed
EP-1858854-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2007-11-28 EP disclosed
WO-2006094639-A1 PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MGLUR5 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-09-14 WO disclosed